Moderna
MRNA
#303
Rank
HK$624.56 B
Marketcap
HK$1,544
Share price
-4.84%
Change (1 day)
695.74%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$624.56 Billion

As of November 2026 Moderna has a market cap of HK$624.56 Billion. This makes Moderna the world's 303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$624.56 B558.45%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Moderna was reported to be:

HK$624.56 Billion
by Nasdaq info icon info icon
HK$624.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.149 T 724.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.299 T 268.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$2.664 T 326.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.43 B-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.35 B-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.53 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$156.95 B-74.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$47.80 B-92.35%๐Ÿ‡บ๐Ÿ‡ธ USA